Comparison of ultrasound-guided erector spinae plane block and thoracic paravertebral block for postoperative analgesia after video-assisted thoracic surgery: a randomized controlled non-inferiority clinical trial
- PMID: 31704789
- DOI: 10.1136/rapm-2019-100827
Comparison of ultrasound-guided erector spinae plane block and thoracic paravertebral block for postoperative analgesia after video-assisted thoracic surgery: a randomized controlled non-inferiority clinical trial
Abstract
Background and objectives: The anesthetic characteristics of ultrasound-guided erector spinae plane block (ESPB) remain unclear. We compared the analgesic efficacies of ESPB and thoracic paravertebral block (TPVB) for analgesia after video-assisted thoracic surgery (VATS).
Method: In this prospective randomized non-inferiority trial, 88 patients undergoing VATS randomly received ESPB or TPVB. All patients received continuous infusion of 0.2% levobupivacaine (8 mL/hour) after injection of a 20 mL 0.2% levobupivacaine bolus. The primary outcome was median differences between the groups in postoperative numerical rating scale (NRS) scores at rest, 24 hours postoperatively.
Results: Eighty-one patients completed the study. The median difference in NRS scores at rest 24 hours postoperatively was 1 (range 0-1), demonstrating the non-inferiority of ESPB to TPVB. NRS scores at rest were significantly lower in the TPVB group at 1, 2 and 24 hours postoperatively (p=0.02, 0.01 and 0.006, respectively). NRS scores on movement were similar. More dermatomes in parasternal regions were anaesthetized in the TPVB group (p<0.0001). Total plasma levobupivacaine concentrations were significantly lower in the ESPB group within 20 hours postoperatively (p=0.036).
Conclusions: The analgesic effect of ESPB after VATS was non-inferior to that of TPVB 24 hours postoperatively.
Trial registration number: UMIN000030658.
Keywords: acute pain; pain outcome measurement; postoperative pain; regional anesthesia; truncal blocks.
© American Society of Regional Anesthesia & Pain Medicine 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: Maruishi Pharmaceutical Cooperation (Osaka, Japan), which produces and distributes levobupivacaine in Japan, provided our hospital with non-financial support. Specifically, this company agreed to measure plasma levobupivacaine concentrations in patient samples without any compensation. We provided blood samples after patients provided written informed consent, and all samples were anonymized. The company was not engaged in this study in any other manner.
Comment in
-
Levobupivacaine plasma level between erector spinae plane block and thoracic paravertebral block.Reg Anesth Pain Med. 2021 Jan;46(1):90-91. doi: 10.1136/rapm-2020-101406. Epub 2020 Apr 8. Reg Anesth Pain Med. 2021. PMID: 32273310 No abstract available.
LinkOut - more resources
Full Text Sources
Medical